Urinary IgM excretion: a reliable marker for adverse pregnancy outcomes in women with chronic kidney disease.

J Nephrol · 2019 · PMC6423310 · PMID 30206800

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

A significant trend towards higher frequency for combined APO was observed across CKD stages: CKD stage 1, 19/59 (32.2%); CKD stage 2, 25/48 (52.1%); CKD stage 3, 25/38 (65.8%); and CKD stages 4–5, 21/22 (95.5%) (p < 0.001).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.